MXene‐Integrated Composites for Biomedical Applications: Synthesis, Cancer Diagnosis, and Emerging Frontiers
Small Science · 2025-04 · 5 (4)
DOI: 10.1002/smsc.202400492 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Science, online erschienen am 17.02.2025. Verfasst von Aryan Saxena und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Chemistry Delhi Technological University Delhi 110042 India. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Chemical Society Petroleum Research Fund.
Abstract (Originalsprache)
MXenes, a novel class of two‐dimensional (2D) transition metal carbides, carbonitrides, and nitrides, have gained significant attention in biomedicine. They are synthesized via two main approaches: top‐down etching of MAX (here, M represents an early transition metal, A represents an element belonging to the A‐group, and X represents N or C) phase precursors and bottom‐up chemical reduction of metal oxides. While the MAX phase method requires high temperatures, influencing morphology and posing safety concerns, alternative non‐MAX synthesis routes are emerging. Due to their unique physical and chemical properties, MXene‐based composites hold great promise in regenerative medicine, biosensing, and cancer therapy. However, challenges related to their stability, controlled drug release, and biodegradability remain. This review explores advancements in MXene synthesis, emphasizing non‐MAX phase fabrication and biomedical applications. Notably, MXene‐based composites have shown remarkable potential in cancer treatment, particularly in photothermal and photodynamic therapy. Their mechanisms, advantages, and limitations are discussed, along with future prospects and challenges in clinical translation. The development of MXene composites offers new avenues for innovative cancer therapies, paving the way for improved treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Applied Chemistry Delhi Technological University Delhi 110042 India.
- Department of Chemical and Biomolecular Engineering (Materials Science and Engineering Program) University of Houston TX 77204 USA.
- Department of Chemical and Biomolecular Engineering University of Houston TX 77204 USA.
ORCID-Profile: Maninderjeet Singh, Alamgir Karim
Förderung
- American Chemical Society Petroleum Research Fund
Zitieren
APA
Saxena, A., Tyagi, A., Vats, S., Gupta, I., Gupta, A., Kaur, R., Tiwary, S. K., Elzatahry, A. A., Singh, M., & Karim, A. (2025). MXene‐Integrated Composites for Biomedical Applications: Synthesis, Cancer Diagnosis, and Emerging Frontiers. Small Science, 5(4). https://doi.org/10.1002/smsc.202400492
Vancouver
Saxena A, Tyagi A, Vats S, Gupta I, Gupta A, Kaur R, et al. MXene‐Integrated Composites for Biomedical Applications: Synthesis, Cancer Diagnosis, and Emerging Frontiers. Small Science. 2025;5(4). doi:10.1002/smsc.202400492
BibTeX
@article{Saxena2025,
author = {Saxena, Aryan and Tyagi, Akshayat and Vats, Sushipra and Gupta, Ishita and Gupta, Akhil and Kaur, Raminder and Tiwary, Saurabh Kr and Elzatahry, Ahmed A and Singh, Maninderjeet and Karim, Alamgir},
title = {MXene‐Integrated Composites for Biomedical Applications: Synthesis, Cancer Diagnosis, and Emerging Frontiers},
journal = {Small Science},
year = {2025},
volume = {5},
number = {4},
doi = {10.1002/smsc.202400492}
}
EUVIMED